Gene Therapy for Rare Disorders Summit

Kongressthemen
Gene Therapy for Rare Disorders 2018 will equip you with the insights to make the most of this unprecedented opportunity. Rather than attempting to cover the entire cell and gene therapy world, this meeting will focus specifically on the critical clinical, manufacturing, regulatory and reimbursement challenges involved in delivering gene therapies to market.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Katherine High (Spark Therapeutics), Philip Gregory (Bluebird Bio), Steven Paul (Voyager Therapeutics), Jude Samulski (Pfizer), Steven Zelenkofske (uniQure), Mary Dunkle (NORD), Sven Kili (GSK), Olivier Danos (REGENXBIO), and Gumei Liu (FDA)

https://go.evvnt.com/178854-2?pid=4832

Customer Services